News summarySeeking AlphaNov 9, 2026, 08:02 PM
Merck MASH asset efinopegdutide meets primary goal in mid-stage trial
Merck MASH asset efinopegdutide meets primary goal in mid-stage trial(摘要待生成)
Loading...
Merck MASH asset efinopegdutide meets primary goal in mid-stage trial(摘要待生成)